Logo
x

Search

Subscribe Now

P-ll

AstraZeneca to Unveil its Robust Pipeline of Breast Cancer at SABCS

AstraZeneca to Unveil its Robust Pipeline of Breast Cancer at SABCS

  • December 3, 2020
BioNTech and Fosun Pharma Initiate P-ll Study of BNT162b2 Against COVID-19 in China

BioNTech and Fosun Pharma Initiate P-ll Study of BNT162b2 Against COVID-19 in China

  • November 26, 2020
Regeneron Pauses Dosing of Garetosmab (REGN2477) in P-II LUMINA-1 Study for Fibrodysplasia Ossificans Progressiva

Regeneron Pauses Dosing of Garetosmab (REGN2477) in P-II LUMINA-1 Study for Fibrodysplasia Ossificans Progressiva

  • November 2, 2020
Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease

Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease

  • October 13, 2020
Amgen Report Five Year Data of Aimovig (erenumab-aooe) in Open-Label Treatment Period of P-II Study for Episodic Migraine

Amgen Report Five Year Data of Aimovig (erenumab-aooe) in Open-Label Treatment Period of P-II Study for Episodic Migraine

  • October 5, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.